Novant Health turns to John Gizdic for an executive handoff
Novant Health is moving into a new leadership phase with Chief Operating Officer John Gizdic set to become president and interim CEO as outgoing president and CEO Carl Armato steps down. The change places a longtime operations leader at the center of one of the region’s major health systems at a moment when continuity matters as much as title changes.
Executive succession in health care is rarely just ceremonial. A transition at the top can ripple through hospital operations, physician alignment, capital planning, labor management, and the daily cadence of patient care, especially when the incoming leader already sits inside the organization’s operating structure. Gizdic’s move from COO to interim chief executive suggests Novant Health is prioritizing institutional continuity while it manages the next stage of its leadership search.
Armato’s departure marks the end of a tenure that has shaped the health system’s recent direction. The caption and announcement identify him as the outgoing president and CEO, while Gizdic’s elevation signals that Novant Health is relying on a leader with direct responsibility for operational execution rather than bringing in an outside caretaker. In systems of Novant’s size, that choice often matters because the interim period is where staff retention, physician confidence, and strategic discipline can quickly either stabilize or fray.
A leadership transition at this level can influence how a health system responds to very practical pressures. Hospital margins remain tight across the industry, workforce strain still shapes staffing decisions, and care delivery increasingly depends on coordination across inpatient, outpatient, and ambulatory settings. A chief operating officer stepping into the top job typically arrives with a detailed understanding of throughput, service-line performance, and the friction points that slow a system down.
Operational continuity becomes the first test
The immediate question is not philosophical; it is operational. Health systems depend on predictable decision-making at the executive level, and an interim CEO must project steadiness quickly while preserving enough flexibility for longer-term strategy.
Gizdic’s background as chief operating officer places him close to the mechanics that define day-to-day performance. That matters because the best-known success metrics in health care are often built from ordinary, repetitive work: bed management, scheduling efficiency, clinical staffing, supply reliability, and coordination across multiple sites of care. When a chief operating officer steps into the top role, the organization is usually signaling confidence that the operational core already knows the business well enough to protect it through transition.
The change also raises the question of how Novant Health will define the interim period. Interim leadership can be brief or extended, depending on the system’s board process and broader succession plans. Even without those details, the appointment itself makes one point clear: Novant Health wants the handoff to feel controlled rather than disruptive.
Leadership shifts can also affect morale in ways that do not show up immediately on a balance sheet. Physicians and staff often watch for clues about whether a new chief executive will preserve established priorities or redirect resources toward different service lines, markets, or performance targets. In a health system environment, where culture and execution are tightly linked, the personality of the transition often influences the speed of organizational adjustment.
What the move says about health system succession
A promotion from inside the executive team usually reflects a preference for institutional memory. It gives the organization time to keep long-running projects moving while the board evaluates the permanent leadership path. It can also help reassure employees and community partners that the system’s basic direction will not abruptly change on the day a new name appears on the office door.
This kind of transition is especially important for integrated systems, where executive leadership affects far more than headline strategy. Hospital performance, employed physician groups, ambulatory expansion, and community-facing initiatives all depend on aligned leadership. The chief executive’s office sets priorities, but the work only succeeds when operational leaders know how to translate them into action without delay.
The appointment of Gizdic also suggests that Novant Health is elevating a leader who has already been embedded in the organization’s operating rhythm. That can help preserve continuity in contract negotiations, service delivery, and internal accountability during a period when many health systems are dealing with cost pressure and a demand for steadier execution.
A brief statement can change the entire feel of a health system when the words are president and interim CEO. In this case, the title change places control in the hands of someone already responsible for the system’s operational machinery.
For patients, the shift may be invisible at the bedside. For the organization behind the bedside, it is a meaningful change in who now carries responsibility for translating strategy into functioning hospitals, clinics, and care teams. The longer-term significance will depend on how the board approaches permanent succession and how smoothly the system navigates the transition already underway.